Frontline: Surgery to remove the tumor is often considered, sometimes followed by chemotherapy or radiation to reduce ...
The early-stage clinical trial marks the first U.S. testing of Alveltamig, an immunotherapy designed to help the immune system better recognize and respond to small cell lung cancer. The study aims to ...
When lung cancer treatment stops working, what happens next? New research reveals the answer may depend on how the cancer grows.
ANDOVER, Mass., Jan. 14, 2026 (GLOBE NEWSWIRE) -- TellBio, Inc., a medical technology company focused on revolutionizing the management of cancer through its unique and proprietary circulating tumor ...
A research team has made a breakthrough in epigenetic drug discovery. The researchers have successfully developed a ...
-- Study Results Support the use of TellDx to Personalize Cancer Care Management – -- Clinical study published in Cancer Discovery -- ANDOVER, Mass., Jan. 14, 2026 (GLOBE NEWSWIRE) -- TellBio, Inc., a ...
Researchers explored why only 40 percent of patients responded to Amgen's Imdelltra using TellBio's liquid biopsy test and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results